H. Michael Shepard - Net Worth and Insider Trading
H. Michael Shepard Net Worth
The estimated net worth of H. Michael Shepard is at least $787,129 dollars as of 2024-11-13. H. Michael Shepard is the VP, Chief Scientific Officer of Halozyme Therapeutics Inc and owns about 13,198 shares of Halozyme Therapeutics Inc (HALO) stock worth over $787,129. Details can be seen in H. Michael Shepard's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that H. Michael Shepard has not made any transactions after 2013-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of H. Michael Shepard
H. Michael Shepard Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, H. Michael Shepard owns 1 companies in total, including Halozyme Therapeutics Inc (HALO) .
Click here to see the complete history of H. Michael Shepard’s form 4 insider trades.
Insider Ownership Summary of H. Michael Shepard
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HALO | Halozyme Therapeutics Inc | 2013-08-19 | See General Remarks |
H. Michael Shepard Latest Holdings Summary
H. Michael Shepard currently owns a total of 1 stock. H. Michael Shepard owns 13,198 shares of Halozyme Therapeutics Inc (HALO) as of August 19, 2013, with a value of $787,129.
Latest Holdings of H. Michael Shepard
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HALO | Halozyme Therapeutics Inc | 2013-08-19 | 13,198 | 59.64 | 787,129 |
Holding Weightings of H. Michael Shepard
H. Michael Shepard Form 4 Trading Tracker
According to the SEC Form 4 filings, H. Michael Shepard has made a total of 0 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years. The most-recent trade in Halozyme Therapeutics Inc is the sale of 10,000 shares on August 19, 2013, which brought H. Michael Shepard around $71,100.
Insider Trading History of H. Michael Shepard
- 1
H. Michael Shepard Trading Performance
H. Michael Shepard Ownership Network
Ownership Network List of H. Michael Shepard
Ownership Network Relation of H. Michael Shepard
H. Michael Shepard Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
H. Michael Shepard is the See General Remarks of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, H. Michael Shepard made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
H. Michael Shepard Mailing Address
Above is the net worth, insider trading, and ownership report for H. Michael Shepard. You might contact H. Michael Shepard via mailing address: 11388 Sorrento Valley Road, San Diego Ca 92121.